ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System

NEXT STORY
XOMA Announces Heather L. Franklin Joins its Board of Directors
PREV STORY
Adagio Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell Infusion in Biologic Refractory Rheumatoid Arthritis Patients

NEW YORK and MELBOURNE, Australia, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) ...

author_avatar
NASDAQ Market News

Arcutis Enrolls First Patient in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-154) as a Potential Treatment for Scalp and Body Psoriasis

author_avatar
NASDAQ Market News

Chinese Precision Medicine Market Set to Witness a Robust CAGR of 12.82% Over 2019-2029 – Cloud-Based Genomics Set to Be the Cornerstone of China’s Precision Medicine Revolution

author_avatar
NASDAQ Market News